FDA approves new osteoporosis drug for post-menopausal women


The FDA has approved a new treatment for post-menopausal women at high risk of breaking bones.

The new osteoporosis drug is called Evenity.

The developers said it can restore bones without breaking them down. 

Doctors should be able to order the drug in about a week. 

It is the first new treatment approach for osteoporosis in nearly two decades. 

Copyright 2021 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories

Don't Miss

More Don't Miss